Related Experiment Video

Updated: Mar 27, 2026

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment
10:33

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Published on: April 25, 2025

1.3K

A highly fluorescent AIE-active theranostic agent with anti-tumor activity to specific cancer cells

Yueyue Zhao1, Ryan T K Kwok, Jacky W Y Lam

  • 1HKUST Shenzhen Research Institute, No. 9 Yuexing 1st Road, South Area, Hi-tech Park, Nanshan, Shenzhen 518057, China. tangbenz@ust.hk.

Nanoscale
|January 20, 2016
PubMed

Insights

Researchers developed a novel theranostic agent for breast cancer, combining cell imaging and therapy. This bright, photostable compound offers new insights into drug development mechanisms.

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Oncology

Background:

  • Tamoxifen is a widely used anti-breast cancer drug.
  • Theranostic agents offer simultaneous diagnosis and therapy.
  • Tetraphenylethene derivatives are known for their fluorescent properties.

Purpose of the Study:

  • To design and synthesize a novel tetraphenylethene derivative with Tamoxifen-like structure.
  • To evaluate its potential as a theranostic agent for breast cancer.
  • To investigate its working mechanism for improved drug development.

Main Methods:

  • Chemical synthesis of the tetraphenylethene derivative.
  • Cell imaging studies using the synthesized compound.
  • In vitro anti-cancer activity assays.

Main Results:

  • Successful synthesis of a Tamoxifen-like tetraphenylethene derivative.
  • Demonstrated high brightness and excellent photostability of the compound.
  • Observed long-term cell tracing capabilities and anti-cancer effects.

Conclusions:

  • The novel tetraphenylethene derivative shows promise as a theranostic agent for breast cancer.
  • Its properties facilitate understanding of working mechanisms, aiding drug development.
  • This research offers new insights into advanced cancer treatment strategies.

More Related Videos

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.7K
Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring08:45

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring

Published on: November 13, 2012

14.4K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K